Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. | President and CEO, Director | Restricted Stock Units | 71.9K | $1.36M | $18.91 | Aug 12, 2024 | Direct |
Edgewise Therapeutics, Inc. | President and CEO, Director | Common Stock | 26.4K | $499K | $18.91 | May 1, 2024 | Indirect |
Edgewise Therapeutics, Inc. | President and CEO, Director | Common Stock | 14.5K | $274K | $18.91 | May 2, 2024 | Direct |
Edgewise Therapeutics, Inc. | President and CEO, Director | Stock Option (Right to Buy) | 431K | Aug 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EWTX | Edgewise Therapeutics, Inc. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | President and CEO, Director |
EWTX | Edgewise Therapeutics, Inc. | May 1, 2024 | 3 | -$59.6K | 4 | May 3, 2024 | President and CEO, Director |
EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2023 | 1 | $0 | 4 | Aug 18, 2023 | President and CEO, Director |
EWTX | Edgewise Therapeutics, Inc. | May 1, 2023 | 3 | -$28.5K | 4 | May 3, 2023 | President and CEO, Director |
EWTX | Edgewise Therapeutics, Inc. | Aug 8, 2022 | 1 | $0 | 4 | Aug 10, 2022 | President and CEO, Director |
EWTX | Edgewise Therapeutics, Inc. | May 1, 2022 | 1 | $0 | 4 | May 3, 2022 | President and CEO, Director |
EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 19, 2021 | President and CEO, Director |